National toxicology program studies: Principles of dose selection and applications to mechanistic based risk assessment

Toxicological Sciences

Volumn 31, Issue 1, 1996, Pages 1-8

  Bucher, J R ^a   Portier, C J ^a   Goodman, J I ^b   Faustman, E M ^c   Lucier, G W ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 26844467019     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/31.1.1     Document Type: Article

References (20)

1. Allen, B. C., Kavlock, R. J., Kimmel, C. A., and Faustman, E. M. (1994). Dose-response assessment for developmental toxicity. II. Comparison of generic benchmark dose estimates with no observed adverse effect levels. Fundam. Appl. Toxicol. 23, 487-495.
2. Ames, B. N., and Gold, L. S. (1990). Chemical carcinogenesis: Too many rodent carcinogens. Proc. Natl. Acad. Sci. USA 87, 7772-7776.
3. Armitage, P., and Doll, R. (1954). The age distribution of cancer and a multistage theory of carcinogenesis. Br. J. Cancer 8, 1-12.
4. Ashby, J., and Tennant, R. W. (1994). Prediction of rodent carcinogenicity for 44 chemicals: Results. Mutagenesis 9(1), 7-15.
5. Chernoff, H. (1953) Locally optimal designs for estimating parameters. Ann. Math. Stat. 24, 586-602.
6. Chhabra, R. S., Huff, J. E., Schwetz, B. A., and Selkirk, J. (1990) An overview of prechronic and chronic toxicity/carcinogenicity experimental study designs and criteria used by the National Toxicology Program. Environ. Health Perspect. 86, 313-321.
7. Cohen, S. M. (1995). Human relevance of animal carcinogenicity studies. Regul. Toxicol. Pharmacol. 21, 75-80.
8. Cohen, S. M., and Ellwein, L. B. (1992). Risk assessment based on high-dose animal exposure experiments. Chem. Res. Toxicol. 5, 742-748.
9. Counts, J. L., and Goodman, J. I. (1994). Hypomethylation of DNA: An epigenetic mechanism involved in tumor promotion. Mol. Carcinog. 11, 185-188.
10. Counts, J. L., and Goodman, J. I. (1995a). Principles underlying dose selection for, and extrapolation from, the carcinogen bioassay: Dose influences mechanism. Regul. Toxicol. Pharmacol. 21, 418-421.
11. Counts, J. L., and Goodman, J. I. (1995b). Alterations in DNA methylation may play a variety of roles in carcinogenesis. Cell 83, in press.
12. Counts, J. L., and Goodman, J. I. (1995c). Hypomethylation of DNA: A possible epigenetic mechanism involved in tumor promotion. In Growth Factors and Tumor Promotion: Implications for Risk Assessment (R. M. McClain, T. J. Slaga, R. A. Leboeuf, and H. C. Pitot, Eds.), pp. 81-101. Wiley-Liss, New York.
13. Faustman, E. M., Allen, B. C., Kavlock, R. J., and Kimmel, C. A. (1994). Dose-response assessment for developmental toxicily. I. Characlerization of database and determination of no observed adverse effect levels. Fundam. Appl. Toxicol. 23, 478-486.
14. Gaylor, D., and Kodell, R. (1980) Linear interpolation algorithm for low dose risk assessment of toxic substances. J. Environ. Pathol. Toxicol. 4, 305-312.
15. Gaylor, D., Chen, J., and Kodell, R. (1985) Experimental design of bioassays for screening and low-dose extrapolation, Risk Analysis 5(1), 9-16.
16. Goodman, J. I. (1990). The carcinogen bioassay in perspective: A requirement for incorporation of biological information. In Vitro Toxicol. 3, 1-7.
17. Goodman, J. I. (1994). A rational approach to risk assessment requires the use of biological information: An analysis of the National Toxicology Program (NTP), final report of the advisory review by the NTP Board of Scientific Counselors. Regul. Toxicol. Pharmacol. 19, 51-59.
18. Meeker, W., and Hahn, G. (1977) Asymptotically optimum over-stress tests to estimate the survival probability at a condition with a low expected failure probability. Technometrics 19(4), 381-399.
19. Melnick, R. L. (1992). Does chemically induced hepatocyte proliferation predict liver carcinogenesis? FASEB J. 6, 2698-2706.
20. Parham, F., Mathews, S., de Rosa, C., and Portier, C. (1995). Using structure-activity data to create physiologically-based pharmacokinetic models for polychlorinated biphenyls. Part I: Tissue to blood partition coefficients. Submitted for publication.